HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

N- (4- methyl- 3- ((4- pyridin- 3- ylpyrimidin- 2- yl)amino)phenyl)- N'- phenylurea

inhibits glycosaminoglycan changes on vascular smooth muscle-derived proteoglycans; structure in first source

Also Known As:

CYC 10424; CYC-10424; CYC10424

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amides: 2428
  - Urea: 15015
    - Phenylurea Compounds: 1
      - N-(4-methyl-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)phenyl)-N'-phenylurea: 1
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Phenylurea Compounds: 1
        N-(4-methyl-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)phenyl)-N'-phenylurea: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrimidines: 510
    - N-(4-methyl-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)phenyl)-N'-phenylurea: 1

Experts

1.	Ballinger, Mandy L: 1 article (11/2008)
2.	Bu, Xianyong: 1 article (11/2008)
3.	Burns, Christopher J: 1 article (11/2008)
4.	Little, Peter J: 1 article (11/2008)
5.	Osman, Narin: 1 article (11/2008)
6.	Su, Stephen: 1 article (11/2008)
7.	Wilks, Andrew F: 1 article (11/2008)

Related Diseases

1.	Atherosclerosis 11/01/2008 - "CYC10424 and related compounds are possible candidates as therapeutic agents for the prevention of lipid deposition as characteristic of diseases such as atherosclerosis."

Related Drugs and Biologics

1.	Lipids